Medicover AB (publ) (MCOV-B) - Net Assets

Latest as of September 2025: Skr5.76 Billion SEK ≈ $619.73 Million USD

Based on the latest financial reports, Medicover AB (publ) (MCOV-B) has net assets worth Skr5.76 Billion SEK (≈ $619.73 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr25.85 Billion ≈ $2.78 Billion USD) and total liabilities (Skr20.09 Billion ≈ $2.16 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MCOV-B tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr5.76 Billion
% of Total Assets 22.28%
Annual Growth Rate 17.31%
5-Year Change 1.2%
10-Year Change 425.0%
Growth Volatility 94.22

Medicover AB (publ) - Net Assets Trend (2005–2024)

This chart illustrates how Medicover AB (publ)'s net assets have evolved over time, based on quarterly financial data. See MCOV-B days of operational coverage to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Medicover AB (publ) (2005–2024)

The table below shows the annual net assets of Medicover AB (publ) from 2005 to 2024. For live valuation and market cap data, see how much is Medicover AB (publ) worth.

Year Net Assets Change
2024-12-31 Skr489.30 Million
≈ $52.66 Million		 -7.38%
2023-12-31 Skr528.30 Million
≈ $56.85 Million		 +3.43%
2022-12-31 Skr510.80 Million
≈ $54.97 Million		 -9.13%
2021-12-31 Skr562.10 Million
≈ $60.49 Million		 +16.26%
2020-12-31 Skr483.50 Million
≈ $52.03 Million		 +34.42%
2019-12-31 Skr359.70 Million
≈ $38.71 Million		 +11.05%
2018-12-31 Skr323.90 Million
≈ $34.86 Million		 +6.55%
2017-12-31 Skr304.00 Million
≈ $32.72 Million		 +207.69%
2016-12-31 Skr98.80 Million
≈ $10.63 Million		 +6.01%
2015-12-31 Skr93.20 Million
≈ $10.03 Million		 +2.98%
2014-12-31 Skr90.50 Million
≈ $9.74 Million		 +284.31%
2005-12-31 Skr23.55 Million
≈ $2.53 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Medicover AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 15334700000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings Skr73.50 Million 15.81%
Common Stock Skr30.70 Million 6.60%
Other Comprehensive Income Skr-56.70 Million -12.20%
Other Components Skr417.30 Million 89.78%
Total Equity Skr464.80 Million 100.00%

Medicover AB (publ) Competitors by Market Cap

The table below lists competitors of Medicover AB (publ) ranked by their market capitalization.

Company Market Cap
Dongfeng Automobile Co Ltd
SHG:600006
 $1.68 Billion
Dime Community Bancshares, Inc.
NYSE:DCOM
 $1.68 Billion
Zhejiang Medicine Co Ltd
SHG:600216
 $1.68 Billion
Zymeworks Inc. Common Stock
NASDAQ:ZYME
 $1.68 Billion
Jiangsu Provincial Agricultural Reclamation and Development Co Ltd
SHG:601952
 $1.68 Billion
PC Connection Inc
NASDAQ:CNXN
 $1.68 Billion
Jiangsu Evergreen New Material Technology Inc. Co. A
SHG:603125
 $1.68 Billion
Taysha Gene Therapies Inc
NASDAQ:TSHA
 $1.68 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Medicover AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 496,500,000 to 464,800,000, a change of -31,700,000 (-6.4%).
  • Net income of 16,700,000 contributed positively to equity growth.
  • Dividend payments of 18,000,000 reduced retained earnings.
  • Other comprehensive income increased equity by 63,700,001.
  • Other factors decreased equity by 94,100,001.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income Skr16.70 Million +3.59%
Dividends Paid Skr18.00 Million -3.87%
Other Comprehensive Income Skr63.70 Million +13.7%
Other Changes Skr-94.10 Million -20.25%
Total Change Skr- -6.38%

Book Value vs Market Value Analysis

This analysis compares Medicover AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 67.86x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 316.03x to 67.86x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2014-12-31 Skr0.66 Skr210.00 x
2015-12-31 Skr0.67 Skr210.00 x
2016-12-31 Skr0.96 Skr210.00 x
2017-12-31 Skr2.52 Skr210.00 x
2018-12-31 Skr2.40 Skr210.00 x
2019-12-31 Skr2.38 Skr210.00 x
2020-12-31 Skr3.16 Skr210.00 x
2021-12-31 Skr3.49 Skr210.00 x
2022-12-31 Skr3.19 Skr210.00 x
2023-12-31 Skr3.32 Skr210.00 x
2024-12-31 Skr3.09 Skr210.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Medicover AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 3.59%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.80%
  • • Asset Turnover: 0.98x
  • • Equity Multiplier: 4.60x
  • Recent ROE (3.59%) is below the historical average (6.66%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2005 5.95% 2.37% 1.46x 1.72x Skr-952.90K
2014 4.85% 1.18% 1.35x 3.04x Skr-4.56 Million
2015 8.41% 1.80% 1.33x 3.51x Skr-1.42 Million
2016 4.64% 0.86% 1.19x 4.53x Skr-4.97 Million
2017 6.23% 3.22% 1.15x 1.68x Skr-11.33 Million
2018 7.70% 3.66% 1.10x 1.91x Skr-7.34 Million
2019 7.09% 2.66% 0.83x 3.21x Skr-9.24 Million
2020 5.76% 2.59% 0.90x 2.48x Skr-19.00 Million
2021 19.67% 7.39% 0.82x 3.25x Skr50.04 Million
2022 2.49% 0.78% 0.82x 3.86x Skr-35.67 Million
2023 3.54% 1.01% 0.90x 3.91x Skr-32.05 Million
2024 3.59% 0.80% 0.98x 4.60x Skr-29.78 Million

Industry Comparison

This section compares Medicover AB (publ)'s net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

  • Industry: Medical Care Facilities
  • Average net assets among peers: $2,413,588,000
  • Average return on equity (ROE) among peers: -5.52%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Medicover AB (publ) (MCOV-B) Skr5.76 Billion 5.95% 3.49x $1.68 Billion
Ambea AB (AMBEA) $1.93 Billion 8.74% 0.79x $1.16 Billion
Attendo AB (publ) (ATT) $4.96 Billion 1.13% 3.25x $1.69 Billion
Humana AB (publ) (HUM) $2.74 Billion 7.67% 2.58x $238.57 Million
ProstaLund AB (PLUN) $25.35 Million -39.61% 0.22x $716.78K

About Medicover AB (publ)

ST:MCOV-B Sweden Medical Care Facilities
Market Cap
$1.68 Billion
Skr15.63 Billion SEK
Market Cap Rank
#6919 Global
#98 in Sweden
Share Price
Skr210.00
Change (1 day)
-1.18%
52-Week Range
Skr182.20 - Skr285.50
All Time High
Skr369.18
Categories
Companies in Sweden Medical Care Facilities
About

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Servi… Read more